Literature DB >> 1959541

Fatal ureaplasmal pneumonia and sepsis in a newborn infant.

F Brus1, W M van Waarde, C Schoots, S B Oetomo.   

Abstract

Ureaplasma urealyticum was isolated in pure culture from blood tracheal aspirate and lung tissue in a newborn infant, who died of a severe pneumonia within 48 h after birth. The clinical course was characterized by persistent pulmonary hypertension of the newborn (PPHN). Post-mortem examination revealed extensive hyaline membrane formation combined with signs of inflammation in both lungs. The clinical and histopathological picture resembled that of early onset group B haemolytic streptococcal pneumonia/sepsis.

Entities:  

Mesh:

Year:  1991        PMID: 1959541     DOI: 10.1007/bf02026711

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  8 in total

1.  Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn.

Authors:  K B Waites; D T Crouse; J B Philips; K C Canupp; G H Cassell
Journal:  Pediatrics       Date:  1989-01       Impact factor: 7.124

2.  Group B streptococcus promotes oxygen radical-dependent thromboxane accumulation in young piglets.

Authors:  L A Shook; T H Pauly; S L Marple; S J Horstman; H H Tai; B D Bowdy; M N Gillespie
Journal:  Pediatr Res       Date:  1990-04       Impact factor: 3.756

3.  Intrauterine infection with Ureaplasma urealyticum as a cause of fatal neonatal pneumonia.

Authors:  P A Quinn; J E Gillan; T Markestad; M A St John; A Daneman; K I Lie; H C Li; E Czegledy-Nagy; A Klein
Journal:  Pediatr Infect Dis       Date:  1985 Sep-Oct

4.  Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants.

Authors:  G H Cassell; K B Waites; D T Crouse; P T Rudd; K C Canupp; S Stagno; G R Cutter
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

5.  Studies on group B beta-hemolytic Streptococcus. II. Effects on pulmonary hemodynamics and vascular permeability in unanesthetized sheep.

Authors:  J Rojas; R S Green; C G Hellerqvist; R Olegard; K L Brigham; M T Stahlman
Journal:  Pediatr Res       Date:  1981-06       Impact factor: 3.756

Review 6.  Role of prostaglandins and thromboxanes in the control of the pulmonary circulation in the fetus and newborn.

Authors:  S Cassin
Journal:  Semin Perinatol       Date:  1980-04       Impact factor: 3.300

7.  Cardiovascular changes in group B streptococcal sepsis in the piglet: response to indomethacin and relationship to prostacyclin and thromboxane A2.

Authors:  B Runkle; R N Goldberg; M M Streitfeld; M R Clark; E Buron; E S Setzer; E Bancalari
Journal:  Pediatr Res       Date:  1984-09       Impact factor: 3.756

8.  Endogenous activity of phospholipases A and C in Ureaplasma urealyticum.

Authors:  N S De Silva; P A Quinn
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

  8 in total
  11 in total

1.  Ureaplasma urealyticum as a cause of pneumonia in preterm infants: analysis of the white cell response.

Authors:  A Panero; L Pacifico; N Rossi; M Roggini; C Chiesa
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

Review 2.  Ureaplasma species: role in diseases of prematurity.

Authors:  Rose M Viscardi
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 3.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

4.  Vaginal Ureaplasma urealyticum colonization: influence on pregnancy outcome and neonatal morbidity.

Authors:  M Abele-Horn; J Peters; O Genzel-Boroviczény; C Wolff; A Zimmermann; W Gottschling
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

5.  Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease.

Authors:  M Abele-Horn; C Wolff; P Dressel; F Pfaff; A Zimmermann
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

6.  Characterization of a murine model of Ureaplasma urealyticum pneumonia.

Authors:  Rose M Viscardi; Jennifer Kaplan; Judith C Lovchik; Ju Ren He; Lisa Hester; Srinivas Rao; Jeffrey D Hasday
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Surfactant protein-A limits Ureaplasma-mediated lung inflammation in a murine pneumonia model.

Authors:  Mobolaji E Famuyide; Jeffrey D Hasday; Heather C Carter; Kirsty L Chesko; Ju-Ren He; Rose M Viscardi
Journal:  Pediatr Res       Date:  2009-08       Impact factor: 3.756

Review 8.  Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.

Authors:  G H Cassell; K B Waites; H L Watson; D T Crouse; R Harasawa
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

9.  Gastric fluid versus amniotic fluid analysis for the identification of intra-amniotic infection due to Ureaplasma species.

Authors:  Sun Min Kim; Roberto Romero; JoonHo Lee; Piya Chaemsaithong; Nikolina Docheva; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-02

10.  Clinical chorioamnionitis at term X: microbiology, clinical signs, placental pathology, and neonatal bacteremia - implications for clinical care.

Authors:  Roberto Romero; Percy Pacora; Juan Pedro Kusanovic; Eunjung Jung; Bogdan Panaitescu; Eli Maymon; Offer Erez; Susan Berman; David R Bryant; Nardhy Gomez-Lopez; Kevin R Theis; Gaurav Bhatti; Chong Jai Kim; Bo Hyun Yoon; Sonia S Hassan; Chaur-Dong Hsu; Lami Yeo; Ramiro Diaz-Primera; Julio Marin-Concha; Kia Lannaman; Ali Alhousseini; Hunter Gomez-Roberts; Aneesha Varrey; Angel Garcia-Sanchez; Maria Teresa Gervasi
Journal:  J Perinat Med       Date:  2021-01-26       Impact factor: 2.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.